Johnson & Johnson products

Corporate Overview

With $15 billion in net sales in 2022, we are the world’s largest pure-play consumer health company by revenue and hold a unique position at the intersection of healthcare and consumer goods.

Built on more than a century of heritage and propelled forward by science, our portfolio of iconic brands – including AVEENO®, BAND-AID® Brand Adhesive Bandages, JOHNSON’S®, LISTERINE®, NEUTROGENA®, TYLENOL®, and ZYRTEC® – are recommended by healthcare professionals and can be trusted by consumers who use our products to improve their daily lives.

Our team members share a digital-first mindset, with an approach to innovation grounded in deep human insights and work every day to earn a place for our consumers’ hearts and homes around the world. Learn more about how everyday care can not only make people well; it can make them whole.

  • $15bn

    2022 Net Sales

  • 3

    Segments

  • 135+

    Year History

  • ~$369bn

    Consumer Health Market

  • 10

    Brands Approximately $400mm1 or More

  • ~1.2bn

    People Served

  • >100

    New Product
    Innovations Each Year Since 2020

  • 36

    #1 Regional Brand Positions

  • >165

    Countries

  • $15bn

    2022 Net Sales

  • 3

    Segments

  • 135+

    Year History

  • ~$369bn

    Consumer Health Market

  • 10

    Brands Approximately $400mm1 or More

  • ~1.2bn

    People Served

  • >100

    New Product
    Innovations Each Year Since 2020

  • 36

    #1 Regional Brand Positions

  • >165

    Countries

Financial News